Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath) - Concepedia

Concepedia

Publication | Closed Access

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)

127

Citations

22

References

2005

Year

Gary D. Myers, Robert A. Krance, Heidi L. Weiss, Ingrid Kuehnle, Gail J. Demmler, H.E. Heslop, Catherine M. Bollard

Bone Marrow Transplantation

TransplantationAlternate DonorAdenovirus Infection RatesPediatric HematologyTransplantation MedicinePediatricsVirologyMedicineBone Marrow Transplants

References

	Year	Citations

Page 1